Oral Delta-9-Tetrahydrocannabinol (THC) Increases Parasympathetic Activity and Supraspinal Conditioned Pain Modulation in Chronic Neuropathic Pain Male Patients: A Crossover, Double-Blind, Placebo-Controlled Trial.
Libat WeizmanHaggai SharonLior DayanJoumana EspaniolSilviu BrillHadas Nahman-AverbuchTalma HendlerGiris JacobPublished in: CNS drugs (2024)
NCT02560545.
Keyphrases
- neuropathic pain
- double blind
- spinal cord
- spinal cord injury
- end stage renal disease
- placebo controlled
- clinical trial
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- study protocol
- prognostic factors
- pain management
- open label
- heart rate variability
- blood pressure
- patient reported outcomes
- phase iii
- drug induced